Clinical Trial Update: Pilot Study of MPB-2043 Enhanced MRI for Nodal Staging in Head and Neck Squamous Cell Carcinomas [Phase 1]

View source ↗

Summary

Phase 1 pilot study evaluating MPB-2043-enhanced MRI for nodal staging in head and neck squamous cell carcinoma; the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• MPB-2043

Snippet

Sponsor: MegaPro Biomedical Co. Ltd. | Conditions: Head and Neck Squamous Cell Carcinoma, Lymph Node Metastasis | Phase 1 | Status: RECRUITING